Copd Stocks List

Recent Signals

Date Stock Signal Type
2021-04-15 APLS 50 DMA Resistance Bearish
2021-04-15 APLS Bollinger Band Squeeze Range Contraction
2021-04-15 APLS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-15 OTRK 20 DMA Resistance Bearish

Recent News for Copd Stocks

Date Stock Title
Apr 15 OTRK 8 Stocks With The Highest Short Percent Of Float
Apr 15 OTRK Lawsuits Filed Against IQDNX, OTRK and ROOT - Jakubowitz Law Pursues Shareholders Claims
Apr 15 OTRK FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ontrak, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
Apr 14 OTRK LAWSUITS FILED AGAINST OTRK, ROOT and EBON - Jakubowitz Law Pursues Shareholders Claims
Apr 14 OTRK The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OTRK, NEPT and EBON
Apr 14 OTRK ATNX & OTRK Upcoming Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Apr 14 OTRK The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IQDNX, OTRK and CYDY
Apr 14 OTRK Ontrak, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Apr 14 OTRK CLASS ACTION UPDATE for FUBO, VLDR and OTRK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Apr 13 OTRK SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ontrak, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - OTRK
Apr 13 OTRK SHAREHOLDER ALERT: OTRK CYDY NEPT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Apr 13 APLS Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
Apr 13 OTRK The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, OTRK and GOEV
Apr 13 OTRK Rosen, A Respected and Leading Firm, Encourages Ontrak, Inc. Investors to Secure Counsel Before Important Deadline - OTRK
Apr 12 OTRK The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IQDNX, OTRK and RIDE
Apr 12 OTRK CLASS ACTION UPDATE for OTRK, ATNX and ROOT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Apr 12 OTRK ATNX & OTRK Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Apr 12 OTRK Lawsuits Filed Against FUBO, APA and OTRK - Jakubowitz Law Pursues Shareholders Claims
Apr 12 OTRK UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ontrak, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 12 OTRK 28 Stocks Moving in Monday's Pre-Market Session
Related Industries: Biotechnology Medical Care

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually, everyday activities such as walking or getting dressed become difficult. Chronic bronchitis, and emphysema are older terms used for different types of COPD. The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years. Those with such a cough are at a greater risk of developing COPD. The term "emphysema" is also used for the abnormal presence of air or other gas within tissues.The most common cause of COPD is tobacco smoking, with a smaller number of cases due to factors such as air pollution and genetics. In the developing world, common sources of air pollution are wood combustion and cooking fires. Long-term exposure to these irritants causes an inflammatory response in the lungs, resulting in narrowing of the small airways and breakdown of lung tissue. The diagnosis is based on poor airflow as measured by lung function tests. In contrast to asthma, the airflow reduction generally does not improve much with the use of a bronchodilator.Most cases of COPD can be prevented by reducing exposure to risk factors. This includes decreasing rates of smoking and improving indoor and outdoor air quality. While treatment can slow worsening, no cure is known. COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. Some people may benefit from long-term oxygen therapy or lung transplantation. In those who have periods of acute worsening, increased use of medications, antibiotics, steroids, and hospitalization may be needed.As of 2015, COPD affected about 174.5 million people (2.4% of the global population). It typically occurs in people over the age of 40. Males and females are affected equally commonly. In 2015, it caused 3.2 million deaths, more than 90% in the developing world, up from 2.4 million deaths in 1990. The number of deaths is projected to increase further because of higher smoking rates in the developing world, and an ageing population in many countries. It resulted in an estimated economic cost of US$2.1 trillion in 2010.

More about Copd
Browse All Tags